
Psychiatric evaluation notes document a comprehensive mental health assessment including chief complaint, psychiatric history, mental status examination, diagnostic formulation, and treatment planning to establish a baseline clinical presentation and diagnostic impression.
These specialized records provide legal protection by demonstrating thorough evaluation of suicidality, homicidality, and capacity while meeting regulatory requirements for psychiatric documentation and supporting medical necessity for proposed interventions.
They guide collaborative care by communicating critical clinical information about symptom severity, functional impairment, and treatment recommendations to the interdisciplinary mental health team throughout the therapeutic relationship.
Psychiatric evaluation notes facilitate crucial communication between psychiatrists, therapists, nurses, and other mental health professionals involved in a patient's treatment team.
These clinical documents serve as legal records that demonstrate adherence to psychiatric care standards, support medical necessity for treatments, and provide protection in malpractice situations.
Comprehensive psychiatric evaluation notes contribute to improved treatment outcomes by ensuring continuity of care, appropriate medication management, and thorough tracking of symptom progression.
Begin the psychiatric evaluation by documenting patient demographics, referral source, presenting problems, and a thorough mental status examination using objective clinical language.
Include comprehensive sections covering chief complaint, history of present illness, psychiatric history, medical history, family psychiatric history, substance use assessment, medication review, psychosocial history, mental status examination, DSM-5 diagnosis, and treatment recommendations.
Maintain clinical objectivity by separating observable behaviors from interpretations, using direct patient quotations when relevant, and avoiding stigmatizing language or unnecessary jargon.
A complete psychiatric evaluation should include the mental status examination (MSE) covering appearance, behavior, mood, affect, speech, thought process, thought content, perception, cognition, insight, and judgment.
The diagnostic formulation synthesizes clinical findings to support DSM-5 diagnoses while explaining symptom etiology, precipitating factors, and psychodynamic considerations influencing the patient's presentation.
Treatment planning sections must avoid vague recommendations, instead specifying medication dosages, therapy modalities, level of care determinations, safety planning details, and concrete follow-up timelines.
Document relevant risk and protective factors including suicidal/homicidal ideation, specific psychiatric symptoms, functional impairments, and strength-based observations that support clinical decision-making.
Ensure HIPAA compliance by limiting disclosures to relevant treatment information, securing electronic records, obtaining appropriate consent for sharing information, and implementing minimum necessary standards when documenting sensitive psychiatric history.
Implement psychiatric-specific documentation templates with structured fields for MSE components, standardized rating scales (PHQ-9, GAD-7, AIMS), and medication tracking to streamline comprehensive evaluations.
Automating psychiatric documentation enables standardized collection of symptoms using validated assessment tools while ensuring critical safety elements are consistently addressed in each evaluation.
When transitioning to electronic psychiatric documentation, utilize customizable templates with drop-down menus for common mental status findings while preserving fields for narrative details of patient-specific clinical presentations.
Suicide risk documentation should comprehensively capture presence or absence of ideation, plan, intent, access to means, protective factors, specific risk factors, previous attempts, any safety planning completed, clinical decision-making regarding level of care, and specific follow-up arrangements made.
Document each psychotropic medication tried previously with dosage ranges, duration of treatment, specific response (using measurement-based care metrics when possible), side effects experienced, reason for discontinuation, and the patient's subjective experience with each medication trial.
Clearly document capacity assessment findings by describing the patient's understanding of their condition, proposed treatments, risks and benefits, alternatives discussed, ability to manipulate information rationally, ability to communicate a choice, and specific determinations made regarding capacity for treatment decisions.
Comprehensive psychiatric evaluation documentation serves as the foundation for effective treatment planning, interdisciplinary communication, legal protection, and continuity of mental health care.
Leveraging standardized psychiatric assessment tools, structured templates, and electronic documentation systems can significantly enhance clinical thoroughness while reducing documentation burden on mental health providers.
Psychiatric Evaluation Notes
Chief Complaints (C/C):
• Persistent feelings of sadness and hopelessness.
• Difficulty concentrating and remembering details, leading to performance issues at work.
• Increased irritability and frustration, especially with colleagues.
• Trouble sleeping, often waking up in the middle of the night.
• Lack of motivation to engage in activities once enjoyed.
• Feelings of isolation despite being in a committed relationship.
• Occasional thoughts of worthlessness and questioning life purpose.
Subjective Section:
History of Presenting Illness (HPI):
The patient is a 34-year-old female who presents with a 6-month history of depressive symptoms, including persistent low mood, irritability, anhedonia, and concentration difficulties. She reports the onset of symptoms following the unexpected loss of her mother to cancer. The patient has been struggling with feelings of profound sadness and loss, which have gradually escalated. Over the past few months, the patient has become increasingly disengaged from work and social activities, and reports decreased energy levels, particularly in the mornings.
She notes that work-related stress has compounded her emotional difficulties, with mounting responsibilities and a lack of support from colleagues. The patient’s daily functioning has been significantly affected, leading to missed workdays and diminished productivity.
The patient previously sought therapy three years ago for situational depression following a breakup, which she described as helpful. However, she stopped attending sessions after a few months due to improvement in symptoms. This time, she reports difficulty coping with both grief and work pressures. She acknowledges using alcohol occasionally to self-soothe but denies any history of substance abuse.
The patient’s support system includes her spouse, who has been emotionally supportive, but she feels distant from her friends and has not been able to reach out to them for help. She is concerned about her inability to maintain relationships and her decreasing interest in social activities.
Aggravating Factors:
• Recent Work Stress: Increased workload and lack of recognition from her superiors, contributing to feelings of helplessness.
• Grief: The death of her mother six months ago remains a significant source of distress.
• Sleep Disturbances: Difficulty maintaining restful sleep, leading to daytime fatigue and worsening mood.
• Isolation: Increasing withdrawal from social interactions, exacerbating feelings of loneliness and depression.
Easing Factors:
• Support from Spouse: The patient reports feeling comforted by her spouse’s encouragement to engage in therapy and talk about her feelings.
• Exercise: Daily walks in the park provide temporary relief and a sense of peace, although she has not been able to engage in this activity consistently.
• Mindfulness Practices: The patient has tried meditation and breathing exercises in the past, which helped reduce anxiety, but has not practiced them recently.
Medications:
• Fluoxetine 20 mg daily: Patient reports some improvement in mood initially, but symptoms have persisted and worsened over the last month.
• Occasional use of over-the-counter sleep aids: Patient has been using melatonin 3 mg on nights when sleep disturbance is particularly problematic.
Patient Goals and Concerns:
• The patient is hoping to find relief from feelings of hopelessness and regain motivation for daily activities.
• Concern about the impact of her depression on her work and relationships, specifically feeling like a burden to her spouse.
• Questions whether medication alone is sufficient or if a combination of therapy and lifestyle changes would be more effective.
Lifestyle Factors:
• Stress: High levels of stress at work, particularly with recent changes in her responsibilities.
• Exercise: Occasional walking, but patient reports lack of motivation to engage in more strenuous physical activity.
• Nutrition: Diet is often irregular, with limited preparation of fresh meals. Patient reports relying on take-out and quick meals due to low energy.
• Sleep Hygiene: Difficulty falling asleep and staying asleep, with disrupted sleep patterns.
• Social Connections: Some strain in relationships with friends, as patient feels disconnected and overwhelmed.
• Substance Use: Occasional alcohol use in the evenings to help cope with stress, but no signs of dependency.
• Impulsivity: No significant concerns about impulsivity or risk-taking behaviors.
Objective Section:
Mental Status Examination (MSE):
• Appearance: Well-groomed, appropriately dressed for the weather, but appears fatigued with slight signs of poor sleep hygiene.
• Behavior: Cooperative but somewhat withdrawn during the session, occasionally fidgeting with hands.
• Thought Process: Linear and goal-directed, though occasional signs of ruminative thinking regarding her mother’s death and work stress.
• Mood: Depressed, with occasional tearfulness. The patient described her mood as “feeling numb most days,” expressing a lack of hope for the future. “I feel like I’m stuck in this cycle and can’t find a way out.”
• Affect: Restricted affect, with minimal emotional expression.
• Speech: Normal rate and volume, though speech is often slow due to fatigue.
• Cognitive Function: Alert and oriented to person, place, and time. Recent and remote memory intact, but the patient reports difficulty concentrating, especially at work.
• Judgment and Insight: Insight into her condition is good; judgment is intact, although the patient reports feelings of indecision in making plans for the future.
Psychiatric Review of Systems (ROS) & History:
• Mood Disorders: Chronic low mood with episodes of irritability.
• Anxiety: Occasional feelings of nervousness, but not pervasive.
• Sleep: Significant sleep disturbance; difficulty falling asleep and staying asleep.
• Appetite: No significant changes in appetite, though meals are often irregular.
• Substance Use: Occasional alcohol use, but no signs of abuse or dependence.
• Previous Psychiatric History: Past history of depression treated with therapy and brief pharmacotherapy (Fluoxetine), with successful outcomes.
• Therapy History: Patient has previously engaged in therapy for situational depression but has not continued since that period.
• Violence/Legal History: No history of violence or legal issues.
Risk Assessment:
• Suicidal Ideation: The patient denies current suicidal ideation, but there are passive thoughts of death, particularly tied to feelings of worthlessness. No plan or intent to harm herself.
• Homicidal Ideation: Denies any homicidal thoughts.
• Safety Concerns: The patient appears to be at low risk for immediate harm but reports a sense of emotional numbness and feeling disconnected from her emotions.
Clinical Impression & Treatment Plan:
Diagnoses:
• Major Depressive Disorder, Recurrent, Moderate (DSM-5)
• Evidence of a persistent depressive episode lasting over six months with significant functional impairment.
• Generalized Anxiety Disorder (DSM-5)
• Occasional symptoms of anxiety, particularly related to work and the patient’s perceived inability to cope.
Treatment Overview:
• Therapy Options Discussed:
• Cognitive-behavioral therapy (CBT) to address negative thinking patterns and improve coping mechanisms.
• Grief counseling to process unresolved grief from the death of the patient’s mother.
• Consideration for additional pharmacological intervention if symptoms persist or worsen.
• Informed Consent: The patient was informed about the risks and benefits of therapy and medication, including potential side effects of antidepressants.
Treatment Goals:
• Short-term Goals:
• Reduce symptoms of sadness and hopelessness.
• Improve sleep patterns and reduce anxiety related to work.
• Long-term Goals:
• Enhance coping skills for grief and stress management.
• Re-engage with social activities and work with improved energy and motivation.
Medication Management:
• Fluoxetine 20 mg daily: Continue for depression management.
• Discussed the option of adding a sleep aid (e.g., trazodone) if sleep disturbances do not improve within 2-3 weeks.
• Alcohol Abstention: Advised reducing alcohol use to improve sleep quality and overall mental health.
Lifestyle Recommendations:
• Exercise: Encourage daily physical activity, such as walking or yoga, to help reduce stress and improve mood.
• Nutrition: Suggest more regular meal planning and a focus on healthy eating to support overall well-being.
• Sleep Hygiene: Establish a consistent sleep schedule and avoid alcohol and screens before bedtime.
Labs and Medical Care:
• Labs: No labs indicated at this time.
• Referral: Consider referral to a grief counselor for additional support if needed.
Reassessment and Next Appointment:
• Next Appointment: Follow-up in 2 weeks to reassess mood symptoms and response to therapy and medications. A re-evaluation of sleep and anxiety will also be included.
Additional Notes:
• The patient was engaged in the session but appeared emotionally fatigued. She expressed hope that therapy would help her feel more “in control” of her emotions and life, showing insight into her depressive symptoms.